Markets have been grinding through a consolidation phase since late January — one that was long overdue. Metals had climbed faster and steeper than anything I'd witnessed before. That pullback won't last much longer. The broader equity market may well be headed for a serious collapse, and when that happens, the most heavily traded names will bleed out the hardest. Natural resource stocks, in the end, will be the last place standing. The debt-fueled Western financial order is unraveling, and economic gravity is pulling toward the East and South as physical assets reassert their primacy over paper shuffling.
I've covered GoldHaven Resources Corp. (GOH:CSE; GHVNF:OTCQB; 4QS:FSE) several times, most recently back in early January. The stock opened the year at CA$0.10 — dirt cheap, as I noted at the time. Within a month, it had climbed to CA$0.39, a 290% move in four weeks. That's the kind of thing deeply undervalued stocks tend to do.
During 2025, GoldHaven secured CA$500,000 in flow-through financing, capital that must be deployed within Canada. A press release on January 6 laid out what the company achieved at its Magno property in BC's Cassiar district, and the assay results were strong enough to explain the rapid share price appreciation. For 2026, the company has secured an additional CA$2.04 million in flow-through funds, leaving it fully capitalized for a 5,000-meter drill program beginning this summer and running until the ground freezes in October, along with a planned airborne survey.
Then on April 30, GoldHaven announced a CA$5 million LIFE financing to push Magno toward a 10,000-meter drill program this year. Unlike flow-through capital, the LIFE structure pairs a share at CA$0.25 with a two-year half warrant at CA$0.35 — and crucially, those shares become freely tradeable upon closing. The stock dipped to CA$0.255 on the news, but I'd expect it to recover once the financing wraps up. That CA$4 million earmarked for Magno carries real significance given that tungsten prices have surged 400% following Chinese restrictions on critical mineral exports.
Running parallel to the Magno push is GoldHaven's Plan B: Copeçal, a potentially district-scale gold project in Brazil. On May 1, the company released findings from an independent technical review confirming a large-scale hydrothermal gold system, anchored by a 6-kilometer gold-in-soil anomaly. Management intends to direct a portion of the LIFE proceeds toward a 5,000-meter drill program at Copeçal, designed to test the structurally controlled gold targets.
When I first wrote about GoldHaven back in July 2025, the entire company was valued at roughly CA$4 million. That figure now sits around CA$14 million — still modest by any reasonable measure. I'll be watching the Magno drill results closely. The tungsten intercepts already in hand hint at something potentially significant in a metal that has abruptly gone from overlooked to critically scarce.
Important Disclosures:
- Bob Moriarty: I, or members of my immediate household or family, own securities of: GoldHaven. My company has a financial relationship with: GoldHaven. My company has purchased stocks mentioned in this article for my management clients: None. I determined which companies would be included in this article based on my research and understanding of the sector.
- Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
